J Natl Compr Canc Netw
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.
ABSTRACT
The NCCN Guidelines for Management of Immunotherapy-Related Toxicities provide interdisciplinary guidance on the management of immune-related adverse events (irAEs) resulting from cancer immunotherapy. These NCCN Guidelines Insights describe symptoms that may be caused by an irAE and should trigger further investigation, and summarize the NCCN Management of Immunotherapy-Related Toxicities Panel discussions for the 2020 update to the guidelines regarding immune checkpoint inhibitor-related diarrhea/colitis and cardiovascular irAEs.
Related Questions
New answer by Medical Oncologist at The Ohio State University School of Medicine (October 17, 2022)
This is a good question and unfortunately becoming more frequent. The bottom line is that to my knowledge at least, we have no good prospective data - let alone results of ran...